
News|Articles|April 2, 2005
- Pharmaceutical Technology-04-02-2005
- Volume 29
- Issue 4
Importance of Background Microbial Levels in the Manufacture and Testing of Sterile Products
Author(s)James P. Agalloco
The sterility testing of samples from an aseptic process may be considered an entirely separate aseptic process that is subject to the same types of adventitious contamination as the aseptic process itself.
Advertisement
Articles in this issue
about 21 years ago
April 2005about 21 years ago
Management Controls for GMP Complianceabout 21 years ago
The Sector Chart: A New Engineering Graph for Pharmaceutical Processesabout 21 years ago
PAT and Process Understanding: A Call to Armsabout 21 years ago
Cold Chain Concernsabout 21 years ago
Evolutions in Direct Compressionabout 21 years ago
X-ray Microtomography of Solid Dosage Formsabout 21 years ago
Orient ExpressAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Roche Gets Priority Review for Enspryng; Announces Sequencing Platform
2
Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection
3
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
4
Regulatory Developments Impacting Biologics
5




